We will be exhibiting at BioJapan 2026

By achieving consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized! [Exhibiting at BioPharma Expo]

We are the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract research and manufacturing services for monoclonal antibodies (mAb), bispecific and multispecific antibodies, antibody-drug conjugates (ADC), enzymes, recombinant proteins, cell therapy products, and plasmid DNA. All manufacturing operations comply with PIC/S GMP standards and meet international regulations. By integrating LIMS and QMS, we achieve an efficient and high-quality manufacturing system. 【Features】 ■ Quality system compliant with GMP and with a track record of regulatory inspections ■ Consistent manufacturing of active pharmaceutical ingredients (DS) and formulations (DP) at the same facility, reducing costs and risks ■ Equipped with dedicated manufacturing facilities that accommodate CHO cells, E. coli, human cell lines, and high-potency formulations ＼ For more details, please check "Download Catalog" ／

• Contract manufacturing
• Various recombination contracts
• Other Contract Life Science Specialization

By ensuring consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

We are the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract research and manufacturing services for monoclonal antibodies (mAb), bispecific and multispecific antibodies, antibody-drug conjugates (ADC), enzymes, recombinant proteins, cell therapy products, and plasmid DNA. All manufacturing is operated in compliance with PIC/S GMP and adheres to international regulations. By integrating LIMS and QMS, we achieve an efficient and high-quality manufacturing system. 【Features】 ■ Quality system compliant with GMP and with a track record of regulatory inspections ■ Consistent manufacturing of active pharmaceutical ingredients (DS) and formulations (DP) at the same facility, reducing costs and risks ■ Equipped with dedicated manufacturing facilities that accommodate CHO cells, E. coli, human cell lines, and high-potency formulations ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By ensuring consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

Our company is the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract development and manufacturing services that cater to a wide range of modalities, including monoclonal antibodies (mAb), multi-specific antibodies, antibody-drug conjugates (ADC), enzyme preparations, recombinant proteins, cell therapy products, and plasmid DNA. We conduct strict manufacturing management based on PIC/S GMP, and with an integrated system environment of LIMS/QMS, we ensure quality assurance throughout the entire product lifecycle. 【Features】 ■ A highly reliable manufacturing system that meets regulatory requirements ■ Support for minimizing manufacturing risks and rapid development through a consistent manufacturing system for active ingredients and formulations ■ Flexible process adaptation in dedicated manufacturing facilities that accommodate multiple cell lines ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By achieving consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

Our company is the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract development and manufacturing services that accommodate a wide range of modalities, including monoclonal antibodies (mAb), multi-specific antibodies, antibody-drug conjugates (ADC), enzyme preparations, recombinant proteins, cell therapy products, and plasmid DNA. We conduct strict manufacturing management based on PIC/S GMP, enabling quality assurance throughout the entire product lifecycle in an integrated system environment with LIMS/QMS. 【Features】 ■ A highly reliable manufacturing system that meets regulatory requirements ■ Support for minimizing manufacturing risks and rapid development through a consistent manufacturing system for active pharmaceutical ingredients and formulations ■ Flexible process adaptation in dedicated manufacturing facilities that accommodate multiple cell lines ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By ensuring consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

Our company is the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for Mycenax Biotech Inc.'s biopharmaceuticals. Mycenax is capable of contract development and manufacturing for a variety of biopharmaceuticals, including antibody drugs. The target formulations include monoclonal antibodies, multi-specific antibodies, ADCs, enzymes, recombinant proteins, cell therapy products, and plasmid DNA. High-quality and efficient manufacturing is possible at our PIC/S GMP-compliant facility that adheres to international standards. With the implementation of a Quality Management System (QMS) and LIMS, we are fully prepared for audits. 【Features】 ■ Compliance with international regulations and proven track record with regulatory inspections ■ Smooth project progress with one-stop manufacturing for DS/DP ■ Equipped with dedicated facilities to support the production of diverse cell lines and high-potency formulations ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By ensuring consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

We are the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract research and manufacturing services for monoclonal antibodies (mAb), bispecific and multispecific antibodies, antibody-drug conjugates (ADC), enzymes, recombinant proteins, cell therapy products, and plasmid DNA. All manufacturing operations are conducted in compliance with PIC/S GMP and adhere to international regulations. By integrating LIMS and QMS, we achieve an efficient and high-quality manufacturing system. 【Features】 ■ Quality system compliant with GMP and with a track record of regulatory inspections ■ Consistent manufacturing of active pharmaceutical ingredients (DS) and formulations (DP) at the same facility, reducing costs and risks ■ Equipped with dedicated manufacturing facilities that accommodate CHO cells, E. coli, human cell lines, and high-potency formulations ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By achieving consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

Our company is the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for Mycenax Biotech Inc.'s biopharmaceuticals. Mycenax is capable of contract development and manufacturing for a variety of biopharmaceuticals, including antibody drugs. The target formulations include monoclonal antibodies, multi-specific antibodies, ADCs, enzymes, recombinant proteins, cell therapy products, and plasmid DNA. High-quality and efficient manufacturing is possible at facilities compliant with international standards and PIC/S GMP. With the implementation of a Quality Management System (QMS) and LIMS, we are fully prepared for audits. 【Features】 ■ Compliance with international regulations and proven track record with regulatory inspections ■ Smooth project progress with one-stop manufacturing for DS/DP ■ Equipped with dedicated facilities to support the production of diverse cell lines and highly active formulations ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

By achieving consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!

We are the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for biopharmaceuticals from Mycenax Biotech Inc. We offer contract research and manufacturing services for monoclonal antibodies (mAb), bispecific and multispecific antibodies, antibody-drug conjugates (ADC), enzymes, recombinant proteins, cell therapy products, and plasmid DNA. All manufacturing operations comply with PIC/S GMP standards and are aligned with international regulations. By integrating LIMS and QMS, we achieve an efficient and high-quality manufacturing system. 【Features】 ■ Quality system compliant with GMP and with a track record of regulatory inspections ■ Consistent manufacturing of active pharmaceutical ingredients (DS) and formulations (DP) at the same facility, reducing costs and risks ■ Equipped with dedicated manufacturing facilities that accommodate CHO cells, E. coli, human cell lines, and high-potency formulations ＼ For more details, please check "Download Catalog" ／

• Other research reagents
• Research Antibodies
• Other contract manufacturing

Currently, a former PPC BD representative is a potential candidate in Japan, making it possible to expand services within the country!

We provide bioanalysis and method development services from Mithra Corporation (based in Taiwan). Our strong positioning as a top-level bioanalytical lab in Taiwan allows us to accurately meet the high-quality analytical needs that are lacking domestically. Additionally, we have a referral system established by former PPC personnel, which provides a significant advantage in building trust with Japanese companies. 【Features】 ■ A bioanalytical lab boasting top-tier capabilities in Taiwan, capable of meeting global standards. ■ A strong alternative to the few bioanalysis labs available in Japan. ■ Comprehensive support from method development to PK/PD analysis. ■ Japanese language support provided by former PPC BD personnel, ensuring smooth communication with clients. ■ A well-established collaboration and referral system, enabling rapid service deployment in the Japanese market. *For more details, please download the PDF (English version) or feel free to contact us.

• Other bio-related products and services

Early testing response at pilot scale! We conduct tests flexibly even in the initial development stage.

Our company conducts BE and PK tests overseas as part of our support for the research and development of generic pharmaceuticals. Under a quality management system based on PMDA guidelines, we provide services that meet the needs of Japanese pharmaceutical companies. The ability to conduct pilot BE/PK tests overseas in a short timeframe and at low cost is a significant advantage, especially for Japanese generic pharmaceutical companies. 【Features】 ■ Responding to the trend of acceptance of overseas test data by PMDA - Appropriate test design is possible based on advanced PMDA materials/policies. ■ Early test response at pilot scale: Flexible testing even in the initial development stage. ■ Competitive pricing compared to Japanese CROs. ■ High-quality data and quick turnaround. - Accelerates decision-making for the next steps without slowing down development speed. ■ Extensive track record of support for Japanese companies: Detailed responses tailored to needs. *For more details, please download the PDF (English version) or feel free to contact us.

• Other contract services

We have analysis results for new ADC pharmaceuticals under development and for marketed products, including Daiichi Sankyo's Enhertu!

"ADC analysis and bioanalysis" is a service that allows for the simultaneous analysis of low molecular weight compounds as well as high molecules such as proteins and antibodies. This service is particularly useful for startup companies and pharmaceutical companies developing biopharmaceuticals (including ADCs), where there is a need to establish new analytical techniques alongside product development. Mithra has extensive experience and solid technical capabilities in the field of bioanalysis, and we welcome inquiries even at the idea stage or early development phase. Please feel free to contact us. [Features] ■ Accumulated technology for integrated development of low molecular and biopharmaceuticals over many years ■ Particularly rich insights in ADC analysis are highly valued by ADC development companies in Taiwan and abroad *For more details, please download the PDF or feel free to contact us.

• Other analysis and evaluation services

We offer a one-stop system that can consistently handle everything from IND application to CMC dossier creation!

Our company provides comprehensive support for regulatory strategies, including IND applications for pharmaceuticals, CTD/CMC dossier preparation, gap analysis, and bridge study evaluations. We can also assist with the design of First-in-Human (FIH) trials, initial dosing, and PK/PD modeling. Our ability to support everything from Pre-IND strategy design to CMC documentation and compliance with Taiwanese regulations at a lower cost than global CROs is highly attractive for companies aiming for global expansion on a limited budget. 【Features】 ■ One-stop system capable of consistent support from IND applications to CMC dossier preparation ■ Expertise in local regulations, particularly focused on Taiwan ■ High level of specialization in initial dosing and PK/PD modeling ■ Significantly better cost efficiency compared to global CROs ■ Early strategy design at the Pre-IND stage enables shortening of development timelines *For more details, please download the PDF (English version) or feel free to contact us.

• Other Testing Contract

Flexible on-site microbial testing (for kitchens and factories) can reduce traditional inspection tasks by half!

We would like to introduce the comprehensive microbiological testing, contract research and development, and cosmetic development services provided by Maple Bio Laboratories, Inc. The ability to manufacture cosmetics that ensure stability without the use of preservatives is a unique strength of the company, which specializes in microbial control. This can greatly contribute to the launch and differentiation of natural-oriented brands. Furthermore, the company boasts a flexible and reliable microbiological testing system that can respond on-site to factories and kitchens, as well as the capability to conduct virus testing for influenza, COVID-19, and other viruses. 【Features】 ■ Capable of conducting virus inactivation tests for multiple viruses, including influenza and human coronaviruses ■ Ability to manufacture stable cosmetics without the use of preservatives through microbial control technology ■ Supports both OEM and ODM, providing seamless assistance from formulation design to product commercialization ■ Has unique achievements under the "LeChene" brand *For more details, please download the PDF or feel free to contact us.

• Other Testing Contract

Partner companies have extensive experience and achievements in the improvement of production strains for useful substances and recombinant technology, and they undertake research and development to meet a wide range of needs.

We provide customized services for the production of metabolites by microorganisms. We offer options for optimizing production and purification processes, as well as improving cost-effectiveness. Additionally, we can accommodate everything from small-scale culture trials to commercial-scale GMP production. *For more details, please download our catalog or feel free to contact us.*

• others

Rich experience and achievements! Contracted research and development that meets the needs of a wide range of clients.

In "Contract Research Organization (CRO) for Strain Improvement and Fermentation Process Development," partner companies have accumulated extensive experience and achievements in the improvement of production strains for useful substances and recombinant technology, providing research and development services that meet the diverse needs of a wide range of clients. We possess a library of 20,000 strains that produce useful substances. We offer comprehensive and high-quality services regarding strain improvement, in vivo changes, fermentation process development, and the provision of microbial NP libraries. 【Features】 ○ Improvement of metabolite yields ○ Suppression of by-product production ○ Enhancement of fermentation processes ○ Provision of microbial libraries ○ Extensive experience with a wide range of strains For more details, please contact us or download the catalog.

• Other contract services

For pharmaceutical companies, biotech ventures, and generic drug companies! Consistent DS/DP manufacturing within the same facility.

We would like to introduce the contract development and manufacturing services for ADCs (Antibody-Drug Conjugates) provided by Mycenax Biotech Inc. Mycenax's main capabilities include end-to-end biopharmaceutical development and manufacturing, contract development and manufacturing services for monoclonal antibodies (mAbs), dual/multiple specificity antibodies, ADCs, and flexible DS (drug substance) / DP (drug product) manufacturing capabilities. Additionally, we are capable of aseptic filling finishes (vials [liquid and lyophilized], pre-filled syringes [PFS], cartridges). 【Features】 ■ Operations compliant with PIC/S GMP, conforming to international regulations, with a track record of regulatory inspections. ■ Consistent DS/DP manufacturing within the same facility minimizes the need for multiple contract management, material transportation, and technology transfer. ■ We have multiple dedicated manufacturing facilities, including those for CHO, E. coli, human cell lines, and high-potency formulations, supporting the development and manufacturing of complex biopharmaceuticals. *For more details, please download the PDF (English version) or feel free to contact us.

• Contract manufacturing

Implementing LIMS (Laboratory Information Management System) and QMS (Quality Management System)!

We would like to introduce the monoclonal antibodies (mAb) provided by Mycenax Biotech Inc., as well as our contract development and manufacturing services for cell and gene therapy pharmaceuticals. The company is a biopharmaceutical CDMO with many years of experience, offering comprehensive development and manufacturing solutions. We can accommodate small-scale manufacturing for clinical trials, as well as large-scale manufacturing for commercial production (50L to 2,000L), and we are capable of aseptic filling (vials [liquid and lyophilized], pre-filled syringes [PFS], cartridges). 【Features】 ■ Operations compliant with PIC/S GMP, conforming to international regulations, with a track record of regulatory inspections ■ Consistent DS/DP manufacturing within the same facility minimizes the need for multiple contract management, material transportation, and technology transfer ■ We have multiple dedicated manufacturing facilities, including those for CHO, E. coli, human cell lines, and high-potency formulations, supporting the development and manufacturing of complex biopharmaceuticals *For more details, please download the PDF (English version) or feel free to contact us.

• Contract manufacturing

Experts in pharmaceutical development will propose services tailored to your company's needs.

In "Pharmacokinetics and Clinical Pharmacology," we provide contract services regardless of the size of the molecules, including biopharmaceuticals and chemically synthesized products. We comprehensively offer the necessary tests for IND packages, including safety pharmacology, pharmacokinetics and metabolism, in vitro and in vivo metabolism, among others. For this service, we have multiple options, and the experts in drug development at Libra Medicina Co., Ltd. will propose services tailored to your company's needs. 【Services】 [Pharmacokinetic Testing] - Evaluation of bridging studies - Preclinical pharmacokinetic research - Toxicokinetic studies - Clinical pharmacokinetic testing - Bioavailability (BA) and bioequivalence (BE) studies, etc. For more details, please contact us or download the catalog.

• Other contract services

Providing all-in-one services from the early research stage to IND!

In "Synthetic Pharmaceutical Development and IND Package," we will appropriately propose services that meet the client's needs from the early research stage to IND. The main contents include synthetic pharmaceutical CMO/cGMP, label body API synthesis, and IND package (including the preparation of application documents), among others. Services related to ADME, safety, and IND packages are not limited to synthetic pharmaceuticals and can also be provided for biopharmaceuticals. [Main Service Contents] - Compound synthesis - Small-scale synthesis - Process development and industrialization - Radioactive compounds, etc. For more details, please contact us or download the catalog.

• Contract manufacturing
• Other contract services

Biopharmaceuticals, particularly biological analysis services for ADCs.

We provide bioanalytical testing services for biopharmaceuticals and small molecules, capable of meeting needs at various stages of development. We specialize in pharmacokinetic analysis of biopharmaceuticals and possess advanced techniques, such as simultaneous analysis of the pharmacokinetics of the antibody portion and the payload portion. Our company offers a comprehensive CRO service, including the planning of biological tests in accordance with ICH Q6B, supporting drug development broadly from exploratory research to application, manufacturing, and clinical trials. For more details, please contact us or download our catalog.

• Other contract services

As an agent for multiple CDMOs in South Korea and Taiwan, we provide intermediary services for contract research and development and manufacturing of synthetic pharmaceutical intermediates, active pharmaceutical ingredients, and formulations.

Regarding active pharmaceutical ingredient manufacturing, we support outsourcing at various stages of new drug development and generic pharmaceuticals, from establishing synthetic methods to small-scale trial production for clinical testing (from grams to kilograms), GMP production, and commercial production. We are also capable of GMP production and regulatory registration for highly contained substances such as anticancer drugs, steroids, and highly pharmacologically active materials. In formulation manufacturing, we mediate contract services for formulation development, manufacturing method formulation research, setting quality standards, developing testing methods, and CMC-related tasks. The CDMO we represent complies with GMP regulations in various countries as well as ICH and PIC/S guidelines. Even at the development stage, we conduct process improvements and data management aimed at market launch, supporting smooth regulatory submissions.

• others

Experts in drug development propose services tailored to your needs!

In the "GLP Safety Testing," we conduct tests tailored to your needs, including toxicity tests, repeated dose tests, safety pharmacology tests, developmental and reproductive toxicity, and biocompatibility tests. All tests conducted are audited by an independent Quality Assurance Unit (QAU) and compiled in compliance with GLP. 【Features】 ○ Supported by a group of toxicity and pathology researchers and experts in laboratory animals ○ All tests conducted are audited by the Quality Assurance Unit ○ Designed to meet the regulatory requirements of various different countries where products are marketed ○ Providing GLP services by experts in accordance with the corresponding guidelines For more details, please contact us or download the catalog.

• Other contract services

GLP bioanalysis compliant with ICH-Q6B for biological products, as well as pharmacokinetics, DMPK, and bioanalysis services for chemical drugs.

1. GLP bioanalysis services compliant with ICH-Q6B for biological products: recombinant proteins, monoclonal antibodies, antibody-drug conjugates (ADCs), vaccines, peptides, glycoproteins. 2. Pharmacokinetics, DMPK, and bioanalysis services for chemical drugs: We provide biological testing services at all stages of drug development, including preclinical, clinical, and post-marketing, not only for biopharmaceuticals but also for small molecule drugs.

• others

Experts in drug development will propose services tailored to your company's needs.

We are currently offering a summary of the bioanalysis testing services provided by Libra Medicina Co., Ltd.! There are multiple analytical methods available, and the experts in pharmaceutical development at Libra Medicina Co., Ltd. will propose services tailored to your company's needs. 【Examples of Services】 <Bioanalysis Testing Services> 　■ Protein Analysis 　■ Pharmaceutical Analytical Method Services 　■ Clinical Trial Services <Pharmaceutical Development Services> 　■ Drug Safety and Metabolism 　■ Compound Development <Non-Clinical Testing Services> 　■ Mammalian Animal Testing 　■ Genotoxicity, etc. *For more details, please contact us or download the information from the link below.

• Other contract services

We have added a new **"Glossary"** to the Hyper CLT sheet website. In the civil engineering and construction industries, there are many specialized terms such as "CLT," "NETIS," "temporary roads," and "wooden lightweight sheets." Therefore, we have introduced related terms in an easy-to-understand manner so that those who are encountering Hyper CLT sheets for the first time can understand the products and technologies. Hyper CLT sheets are wooden lightweight sheets for civil engineering that utilize wood CLT and are registered under the Ministry of Land, Infrastructure, Transport and Tourism's NETIS technology as **"TH-250021-A."** We hope that by not only conveying the features of the product but also sharing the underlying technologies and terminology, users will feel a closer connection to Hyper CLT sheets. We will continue to enhance our website and provide clear information related to wood, NETIS, civil engineering, and CLT.

Hotron Inc. has launched its new product, the "Vehicle Count Sensor CCS3"! This product is a ceiling-mounted sensor that combines infrared and radar technology. It reliably detects vehicles in both directions with a single unit, accommodating traffic during congestion and vehicle passing, thus achieving efficient occupancy management in large parking lots. Additionally, it can be utilized for exit warning purposes in addition to vehicle counting, contributing to the safe and smooth operation of parking facilities. 'Features' - Improved detection performance against changes in road surface during rainy weather by using both infrared and radar. - Equipped with IP67 waterproof and dustproof performance, making it effective even in salt damage areas. - Various settings can be configured from a dedicated app (for Android devices), with current settings easily understandable at a glance. - The base dimensions are the same as the previous model "CCS2," allowing for smooth replacement of existing equipment. *For more details, please refer to the product information, catalog download, or contact us.*

On September 15, 2026, we issued a press release regarding the wooden lightweight sheet "Hyper CLT Sheet." The Hyper CLT Sheet is a civil engineering sheet that utilizes CLT (Cross-Laminated Timber) stacked in an orthogonal direction. It can be used in various locations such as temporary roads, access routes, heavy machinery work yards, and material storage areas. The 5×10 version weighs approximately 230 kg, making it relatively lightweight and easy to install, remove, and relocate. Additionally, it offers environmental benefits such as reducing glare and metallic sounds typical of wood, as well as CO2 fixation. Furthermore, it can be proposed for the use of new technologies in public works as a **registered technology with the Ministry of Land, Infrastructure, Transport and Tourism "TH-250021-A."** Through this press release, we aim to expand the new wooden lightweight sheet that combines wood, NETIS, civil engineering, and CLT to more construction sites.

● The production time for cast prototypes can be shortened! Since model making is not required, the production time for prototypes, which previously took about a month, can be significantly reduced. ● Model costs can be reduced! By directly producing sand molds from 3D data, there is no need for model production costs. If changes to the model are necessary, they can be addressed by modifying the 3D data. ● Similar products with different shapes and dimensions can be prototyped simultaneously! Different products, such as similar shapes or varying dimensions, can be molded at the same time in one molding process. This allows for the verification of multiple types in a short period.

The "HA-T Series" is an energy-saving automatic door sensor that opens only for those who wish to enter, whether on a busy street or in a narrow passageway. The automatic door opens simply by bringing your hand close, addressing hygiene concerns even in facilities used by a large number of people. You can choose between "Non-vision Mount Type/HA-T401" and "Non-vision Built-in Type/HA-T520" depending on the application and installation location. 【Recommended for such places!】 ☑ Entrance facing a busy corridor ☑ Presence of counters or signs near the door ☑ Buildings facing narrow passages ☑ Buildings that prioritize aesthetics ☑ Hospitals and facilities that consider hygiene ☑ Large facilities with many doors 【Features】 ● Adaptable to various door types with four detection spot settings ● Reduces unnecessary opening and closing, contributing to energy-saving by minimizing wasteful power consumption ● Equipped with a light touch function, allowing the door to open and close just by waving your hand, ensuring hygiene ● Can also be used as a wide detection range non-vision infrared sensor ◎ For more details, please download the materials or contact us.